Efficacy and safety profile of busulfan plus low-dose melphalan (BUMEL) versus high-dose melphalan (MEL200) as a conditioning regimen for autologous hematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma patients: a systematic review and meta-analysis
Maqbool, Shahzaib; Khan, Imran; Ibrahim, Muhammad; Thida, Aye Mon; Faisal, Muhamamd Salman; Faraz, Fatima; Khan, Abat; Shahzad, Moazzam; Rehman, Mohammad Ebad Ur; Muhammad, Qurat Ul Ain; Rehman, Abdur
Share
Save